Published in Blood Weekly, January 20th, 2000
The US patent (no. 6006752), titled "Mixed Chimerism and Tolerance," was issued to Megan Sykes, MD, of MGH and licensed exclusively to BioTransplant. The technology covered in the patent is designed to re-educate a recipient's immune system to accept donor cells and organs as "self". The company believes this technology has the potential to expand the number of blood cell cancer and organ transplant patients who can be treated, produce fewer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.